Thursday, July 3, 2025 7/3/2025

Defining Stat3 Antimicrobial Mechanisms in Human Urothelium

Award Number: R03DK140423
ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 06/09/2025
PERIOD OF PERFORMANCE END DATE: 04/30/2027

Group Awards By:

View Award Description

Defining Stat3 Antimicrobial Mechanisms in Human Urothelium - PROJECT SUMMARY/ABSTRACT Urinary tract infections (UTI) are a morbid condition affecting a significant proportion of individuals; yet there has been minimal progress made in their treatment and even prevention beyond antibiotic use. The host-pathogen interaction is an important relationship in UTI pathogenesis and interventions promoting the host innate immune response to reduce UTI susceptibility would be ideal therapeutic measures. The urothelium serves essential roles in the detection and elimination of invading bacteria through expression of bacterial receptors, production of cytokines and chemokines, and secretion of antimicrobial peptides (AMPs). We have previously demonstrated in a murine model of UTI that the interleukin (IL)-6/Signal Transducer and Activator of Transcription (STAT) 3 signaling pathway in the urothelium is important in producing AMPs and eliminating uropathogenic Escherichia coli (UPEC) from the urinary tract. While the transcription factor STAT3 is a central mediator in this process, its contributions to urothelial antimicrobial properties and transcriptional targets are incompletely understood. The objective of this proposal is to define STAT3 mediated host defense mechanisms in human urothelium. This proposal tests the hypothesis that STAT3 and its downstream targets contribute to UTI defense by limiting intracellular and extracellular bacteria urothelial reservoirs necessary for UTI pathogenesis, with the goal that these host mediators could be leveraged in treating and preventing UTI. The novelty of this proposal is the use of CRISPR/Cas9 gene editing in human urothelial cells to study STAT3 biology and the use of RNA-seq to reveal transcriptional targets of STAT3 signaling. The anticipated outcome of this research is to identify the mechanisms by which STAT3 confers host immunity against UTI and reveal its therapeutic targets. Aim 1 will define mechanisms by which STAT3 mediates urothelial defense against UTI in human urothelial cell culture. Aim 2 will identify transcriptional targets of STAT3 that serve instrumental roles in limiting UTI. Together, these Aims seek to implicate STAT3 and its downstream targets as integral components of the host innate immune response to UTI. The completion of this award will broaden our understanding of the mechanisms by which STAT3 signaling impacts UTI and provide candidate transcriptional targets which would be further interrogated in an R01 application.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $117,000 )
2025	2025	RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL	700 CHILDRENS DR	COLUMBUS	OH	43205	FRANKLIN	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	1	6/9/2025	NEW	$117,000
														Subtotal = $117,000

Grand Total All Awards = $117,000

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Defining Stat3 Antimicrobial Mechanisms in Human Urothelium

Award Number: R03DK140423

ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 06/09/2025

PERIOD OF PERFORMANCE END DATE: 04/30/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer